Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Infinity Pharmaceuticals Inc (NASDAQ:INFI)

3.30
Delayed Data
As of Mar 24
 +0.10 / +3.12%
Today’s Change
0.84
Today|||52-Week Range
6.63
+144.44%
Year-to-Date
Pernix: An Investor's Rationale to Staying Long
Mar 23 / GuruFocus News - Paid Partner Content
Infinity Pharma Focuses on Cancer Drug: Competition Looms
Mar 21 / Zacks.com - Paid Partner Content
3 Reasons Why Infinity Pharmaceuticals (INFI) is a Great Momentum Stock
Mar 23 / Zacks.com - Paid Partner Content
Infinity (INFI) Reports Narrower-than-Expected Loss in Q4
Mar 15 / Zacks.com - Paid Partner Content